国产精品丁香六月激情网,_中文字幕丁香五月天婷婷激情六月_欧美精品天天插日日操_中文字幕久久婷婷五月综合色丁香花_日韩精品激情婷婷丁香色五月综合深爱野花_亚洲无码狠狠色丁香婷婷综合_日韩精品五月天激情国产综合婷婷婷_日韩精品亚洲婷婷在线观看

今(jīn)天是(shì)2026年(nián)7月(yuè)22日 星期三,歡迎光臨(lín)本站 上海(hǎi)研生(shēng)實業有限(xiàn)公司 網址: darylliu.cn

一抗

乳腺(xiàn)癌相(xiāng)關蛋(dàn)白2抗體(tǐ)

文字(zì):[大(dà)][中][小] 2017-5-4    瀏覽次數:1836    

英文(wén)名稱 Anti-BCAS2
中文名稱: 乳(rǔ)腺癌(ái)相關(guān)蛋白2抗體(tǐ)
別(bié) 名 DNA amplified in mammary carcinoma 1 protein; Spliceosome associated protein SPF 27; bcas2; Breast carcinoma amplified sequence 2; Breast carcinoma-amplified sequence 2; DAM1; MGC7712; Pre mRNA splicing factor SPF27; Pre-mRNA-splicing factor spf27; SPF27_HUMAN; Spliceosome associated protein amplified in breast cancer; Spliceosome-associated protein SPF 27.

詳細(xì)介(jiè)紹(shào):


濃 度 1mg/1ml
規 格 0.1ml/100μg 0.2ml/200μg
抗體來(lái)源(yuán) Rabbit
克隆類型 polyclonal
交(jiāo)叉反(fǎn)應 Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Horse, Sheep
產(chǎn)品類型 一(yī)抗
研(yán)究領域(yù) 腫瘤 細胞生物 腫瘤(liú)細(xì)胞生物標(biāo)誌物(wù) 表觀遺傳(chuán)學(xué)
蛋(dàn)白(bái)分子(zǐ)量(liáng) predicted molecular weight: 26kDa
性 狀(zhuàng) Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from human BCAS2 (162-210aa)
亞(yà) 型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4
產品應(yīng)用(yòng) WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
(石蠟(là)切片需做抗(kàng)原(yuán)修(xiū)復(fù))
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.

相關資(zī)料:


產品介紹 BCAS2 is a ubiquitously expressed nuclear protein that was originally identified as being overexpressed in various breast cancer cell lines. BCAS2 is now known to be a component of the spliceosome, participating in the removal of introns from mRNA precursors. BCAS2 specifically interacts (in a ligand-independent manner) with thyroid hormone receptor beta, ER alpha (estrogen receptor alpha), PR (progesterone receptor), and PPAR gamma (Peroxisome proliferator-activated receptor gamma). BCAS2 functions as an ER coactivator and is capable of enhancing ER-mediated transcription. This suggests that BCAS2 is involved in the development of breast cancer.
Function : Component of the PRP19-CDC5L complex that forms an integral part of the spliceosome and is required for activating pre-mRNA splicing. May have a scaffolding role in the spliceosome assembly as it contacts all other components of the core complex.
Subunit : Component of the PRP19-CDC5L splicing complex composed of a core complex comprising a homotetramer of PRPF19, CDC5L, PLRG1 and BCAS2, and at least three less stably associated proteins CTNNBL1, CWC15 and HSPA8. Interacts directly in the complex with PRPF19, CDC5L and PLRG1.
Subcellular Location : Nucleus, nucleolus.
Tissue Specificity : Ubiquitously expressed.
Similarity : Belongs to the SPF27 family.
Database links : UniProtKB/Swiss-Prot: O75934.1

返回(huí)上(shàng)一(yī)步(bù)
打印此頁(yè)
[向(xiàng)上(shàng)]

網站(zhàn)首(shǒu)頁

公(gōng)司介(jiè)紹

產(chǎn)品中心

技術服務

技術(shù)文(wén)獻

在綫(xiàn)留(liú)言

聯係(xì)我(wǒ)們

在綫客服

咨詢電話:

請(qǐng)掃描二維碼(mǎ)
打開手(shǒu)機站